Pfizer
Paclitaxel
Manufacturer:
Pfizer
Name:
Paclitaxel
Category:
J Code
HCPCS:
J9267
NDC(s):
62332-0622-50, 62332-0621-17, 62332-0620-05, 00703-3213-01, 00703-3213-81, 00703-3216-01, 00703-3216-81, 00703-3217-01, 00703-3218-01, 00703-3218-81, 16714-0137-01, 44567-0505-01, 44567-0506-01, 45963-0613-86, 47781-0595-07, 61703-0342-09, 61703-0342-22, 61703-0342-50, 63323-0763-05, 63323-0763-06, 63323-0763-16, 63323-0763-17, 63323-0763-50, 63323-0763-52, 67457-0434-51, 67457-0449-17, 67457-0471-52, 68001-0516-27, 70860-0200-05, 70860-0200-17, 70860-0200-50, 70860-0215-68, 70860-0215-66, 45963-0613-56, 70860-0215-67, 45963-0613-83, 45963-0613-89,
Primary Type:
Cancer
Route of Administration:
Intravenous
About:
Paclitaxel is a Cancer drug manufactured by Pfizer and administered via the Intravenous route of administration. The J Code: J9267 is aligned to the drug Paclitaxel.